UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 03)*

CARMIKE CINEMAS, INC

(Name of Issuer)

Common Stock

(Title of Class of Securities)

143436400

(CUSIP Number)

Janet McWilliams, Driehaus Capital Management LLC 25 East Erie Street Chicago, IL 60611 Phone : 312-587-3800

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

August 4, 2016

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ¨

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

1	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) DRIEHAUS CAPITAL MANAGEMENT LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)  x        (b)  ¨
3	SEC USE ONLY
4	SOURCE OF FUNDS     AF
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(e) or 2(f)    ¨
6	CITIZENSHIP OR PLACE OF ORGANIZATION     Delaware, USA
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER
		8	SHARED VOTING POWER     2,430,578
		9	SOLE DISPOSITIVE POWER
		10	SHARED DISPOSITIVE POWER     2,430,578
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON     2,430,578
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES    ¨
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)     9.90%
14	TYPE OF REPORTING PERSON     IA

1	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Driehaus Active Income Fund
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)  x        (b)  ¨
3	SEC USE ONLY
4	SOURCE OF FUNDS     WC
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(e) or 2(f)    ¨
6	CITIZENSHIP OR PLACE OF ORGANIZATION     Delaware, USA
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER
		8	SHARED VOTING POWER     1,735,011
		9	SOLE DISPOSITIVE POWER
		10	SHARED DISPOSITIVE POWER     1,735,011
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON     1,735,011
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES    ¨
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)     7.07%
14	TYPE OF REPORTING PERSON     IV

Item 1. Security and Issuer

This Amendment No. 3 to Schedule 13D (“Amendment No. 3”) amends and supplements the Schedule 13D/A as last amended by Amendment No. 2 filed on June 8, 2016 by Driehaus Capital Management LLC (“DCM”) and Driehaus Active Income Fund (“LCMAX”) relating to the Common Stock, par value $0.03 per share (the “Common Stock”), of Carmike Cinemas, Inc. (the “Company”), a company existing under the laws of Delaware. The principal executive offices of the Company are located at 1301 First Avenue, Columbus, Georgia 31901-2109, telephone (706) 576-3400.

Item 2. Identity and Background

(a) The Reporting Persons are Driehaus Capital Management LLC (“DCM”) and Driehaus Active Income Fund (ticker symbol LCMAX). DCM is a Delaware limited liability company and a registered investment adviser. The executive officers of DCM are Richard H. Driehaus (Chairman), Robert Gordon (President and Chief Executive Officer), Michelle Cahoon (Managing Director, Treasurer and Chief Financial Officer), Janet McWilliams (Managing Director and General Counsel), Stephen Weber (Managing Director, Sales and Relationship Management), Carla Dawson (Managing Director, Human Resources), Thomas Seftenberg (Managing Director, Relationship Management and Marketing), Michael Shoemaker (Chief Compliance Officer), Kenneth Nelson (Managing Director and Portfolio Manager), Maximilian Heitner (Managing Director, Risk Management and Research) and Daniel Rea (Managing Director, Research). DCM does not have a board of directors. The entity controlling DCM is Driehaus Capital Holdings LLLP, a Delaware limited liability limited partnership. Although the instructions to this filing do not require disclosure of information regarding LCMAX’s officers and directors, this information is available in LCMAX’s prospectus and statement of additional information, available at www.driehaus.com.

(b) The address of the principal office of DCM, its controlling entity listed above and its officers listed above is 25 East Erie Street, Chicago, IL 60611. The principal office of LCMAX is 25 East Erie Street, Chicago, IL 60611.

(c) DCM is a registered investment adviser. LCMAX is a series of Driehaus Mutual Funds, an open-end investment company formed in Delaware, and is managed by DCM. The occupations of DCM’s executive officers are noted in “a” above.

(d) During the last five years, the Reporting Persons, controlling entity and executive officers have not been convicted in a criminal proceeding.

(e) During the last five years, the Reporting Persons, controlling entity and executive officers have not been party to a civil proceeding as described in Item 2(e) of Schedule 13D .

(f) All executive officers are US citizens.

Item 3. Source and Amount of Funds or Other Consideration

To acquire the Common Stock, LCMAX and two other registered investment companies advised by DCM used funds totaling $67,503,747.12, inclusive of brokerage commissions. One registered investment company (other than LCMAX) advised by DCM also used funds totaling $156,562.70, inclusive of brokerage commissions, to purchase CKEC call option contracts.

Item 4. Purpose of Transaction

The securities covered by this statement were acquired because the Reporting Persons believe that shares are undervalued. The Reporting Persons believe that such value can be unlocked by exercising their voting rights with respect to the pending transaction with AMC Entertainment Holdings, Inc. (AMC). Following publicly expressed shareholder concern regarding prospective “sandbagging” of company results and/or future guidance, Reporting Persons plan to exercise their statutory right to appraisal. This Schedule 13D is being amended on August 4, 2016 to attach our statement regarding the revised offer made on July 25, 2016 by AMC for Carmike.

(a) As investors in the Company, the Reporting Persons may have discussions with members of Company management, the Company’s board of directors and other shareholders of the Company which may relate to or result in the acquisition by any person of additional securities of the Company, or the disposition of securities of the Company.

(b) As investors in the Company, the Reporting Persons may have discussions with members of Company management, the Company’s board of directors and other shareholders of the Company which may relate to or result in an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Company or any of its subsidiaries.

(c) As investors in the Company, the Reporting Persons may have discussions with members of Company management, the Company’s board of directors and other shareholders of the Company which may relate to or result in a sale or transfer of a material amount of assets of the Company or any of its subsidiaries.

(d) As investors in the Company, the Reporting Persons may have discussions with members of Company management, the Company’s board of directors and other shareholders of the Company which may relate to or result in any change in the present board of directors or management of the Company, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board.

(e) As investors in the Company, the Reporting Persons may have discussions with members of Company management, the Company’s board of directors and other shareholders of the Company which may relate to or result in any material change in the present capitalization or dividend policy of the Company.

(f) As investors in the Company, the Reporting Persons may have discussions with members of Company management, the Company’s board of directors and other shareholders of the Company which may relate to or result in any other material change in the Company’s business or corporate structure including but not limited to, if the Company is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by section 13 of the Investment Company Act of 1940.

(g) As investors in the Company, the Reporting Persons may have discussions with members of Company management, the Company’s board of directors and other shareholders of the Company which may relate to or result in changes in the Company’s certificate of incorporation, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Company by any person.

(h) As investors in the Company, the Reporting Persons may have discussions with members of Company management, the Company’s board of directors and other shareholders of the Company which may relate to or result in causing a class of securities of the Company to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association.

(i) As investors in the Company, the Reporting Persons may have discussions with members of Company management, the Company’s board of directors and other shareholders of the Company which may relate to or result in a class of equity securities of the Company becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act.

(j) As investors in the Company, the Reporting Persons may have discussions with members of Company management, the Company’s board of directors and other shareholders of the Company which may relate to or result in any action similar to any of those enumerated above.

Item 5. Interest in Securities of the Issuer

(a) The aggregate number and percentage of the class of securities identified pursuant to Item 1 beneficially owned by each Reporting Person is stated in Items 11 and 13 on the cover pages hereto.

(b) The number of shares to which each Reporting Person has sole power to vote or direct the vote, shared power to vote or direct the vote, sole power to dispose or to direct the disposition and shared power to dispose or to direct the disposition is stated in Items 7-10 on the cover pages hereto.

(c) The transactions in the class of securities reported on that were effected during the past sixty days by the Reporting Persons are described below. The transactions were effected by DCM as the investment adviser on behalf of LCMAX and two registered investment companies which are series of Driehaus Mutual Funds. One of the registered investment companies (other than LCMAX) advised by DCM also holds CKEC 9/16/16 call option contracts with a strike price of $30. All purchases were effected in the open market.

Transaction Date	Shares or Units Purchased (Sold)			Price Per Share or Unit
3/15/2016		5,800			29.51
3/16/2016		4,571			29.47
3/16/2016		9,143			29.53
3/16/2016		12,143			29.51
3/16/2016		12,143			29.53
3/16/2016		62,000			29.70
3/16/2016		1,828			29.47
3/16/2016		3,657			29.53
3/16/2016		4,857			29.51
3/16/2016		4,857			29.53
3/16/2016		24,801			29.70
3/17/2016		18,700			29.51
3/17/2016		25,000			29.70
3/17/2016		59,141			29.62
3/17/2016		18,700			29.51
3/17/2016		25,000			29.70
3/17/2016		59,141			29.62
3/18/2016		146			29.63
3/18/2016		51,268			29.70
3/18/2016		73,239			29.59
3/18/2016		135,347			29.69
3/18/2016		54			29.63
3/18/2016		18,732			29.70
3/18/2016		26,761			29.59
3/18/2016		49,453			29.69
3/18/2016		1500 contracts [9/16/16 Call Option @$30	]		0.95 per underlying share
3/18/2016		98 contracts [9/16/16 Call Option @$30	]		0.8 per underlying share
3/21/2016		5,100			29.53
3/21/2016		37,212			29.58
3/21/2016		47,040			29.60
3/21/2016		121,163			29.60
3/21/2016		1,700			29.53
3/21/2016		12,404			29.58
3/21/2016		15,680			29.60
3/21/2016		40,388			29.60
3/21/2016		1,700			29.53
3/21/2016		12,404			29.58
3/21/2016		15,680			29.60
3/21/2016		40,388			29.60
3/21/2016		53 contracts [9/16/16 Call Option @$30	]		0.85 per underlying share
3/22/2016		9,513			29.66
3/22/2016		16,260			29.69
3/22/2016		33,170			29.65
3/22/2016		36,524			29.72
3/22/2016		56,748			29.68
3/22/2016		70,315			29.66
3/22/2016		919			29.66
3/22/2016		1,572			29.69
3/22/2016		3,207			29.65
3/22/2016		3,531			29.72
3/22/2016		5,486			29.68
3/22/2016		6,797			29.66
3/22/2016		1,268			29.66
3/22/2016		2,168			29.69
3/22/2016		4,423			29.65
3/22/2016		4,870			29.72
3/22/2016		7,566			29.68
3/22/2016		9,375			29.66
3/23/2016		958			29.71
3/23/2016		6,254			29.70
3/23/2016		8,712			29.70
3/23/2016		11,674			29.91
3/23/2016		19,178			29.92
3/23/2016		60,854			29.90
3/23/2016		70,169			30.05
3/23/2016		96,617			29.64
3/23/2016		138,909			29.86
3/23/2016		142			29.71
3/23/2016		924			29.70
3/23/2016		1,288			29.70
3/23/2016		1,726			29.91
3/23/2016		2,835			29.92
3/23/2016		8,996			29.90
3/23/2016		10,372			30.05
3/23/2016		14,283			29.64
3/23/2016		20,534			29.86
4/15/2016		45,833			30.03
4/15/2016		82,500			30.04
4/15/2016		91,667			30.07
4/15/2016		4,167			30.03
4/15/2016		7,500			30.04
4/15/2016		8,333			30.07
4/18/2016		9,091			30.11
4/18/2016		22,727			30.12
4/18/2016		30,909			30.10
4/18/2016		137,273			30.18
4/18/2016		909			30.11
4/18/2016		2,273			30.12
4/18/2016		3,091			30.10
4/18/2016		13,727			30.18

(d) In addition to LCMAX, two other investment companies which are series of Driehaus Mutual Funds have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sales of, the securities covered by this statement. LCMAX has the right and power with respect to more than 5% of the shares of Common Stock.

(e) Not applicable.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

One of the registered investment companies (other than LCMAX) advised by DCM also holds 1,651 CKEC 9/16/16 call option contracts with a strike price of $30 (as shown in Item 5c).

Except as otherwise described herein, none of the Reporting Persons or, to the Reporting Persons’ knowledge, the controller or executive officers has any contracts, arrangements, understandings or relationships (legal or otherwise) with any other person with respect to any securities of the Company.

Item 7. Material to Be Filed as Exhibits

Exhibit 1. Statement from DCM regarding the acquisition of Carmike Cinemas, Inc.

Exhibit 2. Joint Filing Agreement

Exhibit 3. Analysis of Proposed Sale of Carmike Cinemas, Inc. to AMC Entertainment Holdings Inc.

Exhibit 4. Statement from DCM regarding the revised Carmike Cinemas, Inc. offer

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

	Driehaus Capital Management LLC
August 5, 2016	By:	/s/ Janet McWilliams
		Managing Director and General Counsel
	Driehaus Mutual Funds
August 5, 2016	By:	/s/ Janet McWilliams
		Chief Legal Officer and Assistant Vice President

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of the filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement: provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

Footnotes:

Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)